In agreement with these previous studies, our data showed that TMZ treatment caused upregulation of PERK/eIF2α/ATF4 signaling in GBM cells, while inhibition of ATF4 in TMZ-resistant GBM cells not only prevented the migration and invasion abilities but also enhanced cell apoptosis. The gene discussed is EIF2AK3; the disease is glioblastoma.